Dyadic International Inc (DYAI) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dyadic International Inc   (NASDAQ: DYAI)


Dyadic International Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Dyadic International Inc 's ROA in the second quarter of 2026?
Dyadic International Inc recorded a cumulative net loss of $-8 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -46.56%.

However, within the Healthcare sector 702 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4164, from total ROA ranking in the first quarter of 2026 at 4862.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 341.36 % -0.13 % -72.97 % 8.62 % -23.45 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -8 -7 -7 -7 -6
Return On Assets (TTM) -46.56 % -77.35 % -78.11 % -45.53 % -35.05 %
DYAI's Total Ranking # 4164 # 4862 # 4276 # 4189 # 4262
Total Assets (TTM) in million 36 8 10 12 8
Seq. Total Assets Change 355.56 % -20.73 % -15.26 % 44.23 % 3.08 %
Seq. Net Income Change - - - - -

DYAI's 5 Years Annual ROA >> Back to DYAI Management Effectiveness >> Compare DYAI ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 109
Sector # 703
Overall # 4158

Return On Assets Statistics
High Average Low
21191.59 %
1998.85 %
-104.68 %
(Sep 30 2023)   (Dec 31 2021)



  News about Dyadic International Inc Return on Assets ROA

Dyadic International Secures $3 Million Grant for Affordable Monoclonal Antibodies Despite Ongoing Financial Challenges,

Dyadic International Secures $3 Million Grant for Affordable Monoclonal Antibodies Amidst Financial StrugglesIntroductionDyadic International, Inc. (NASDAQ: DYAI), a burgeoning biotechnology company, recently announced it has received a significant $3 million grant from the Bill and Melinda Gates Foundation. This funding is earmarked for the development of cost-effective monoclonal antibodies to combat respiratory syncytial virus (RSV) and malaria, highlighting the company s commitment to affordable healthcare solutions. However, this financial support comes at a time when Dyadic is grappling with substantial cumulative net losses and a notably low return on assets (ROA).The Grant and Its SignificanceThe grant from the Bill and Melinda Gates Foundation is a pivotal development for Dyadic International, enabling it to enhance its research and development efforts in creating affordable therapeutics. This initiative aligns with the Gates Foundation s mission to improve global health by ensuring that critical medicines are accessible to underserved populations.



Financial Statements
Dyadic International Inc 's Assets $ 36 million DYAI's Balance sheet
Dyadic International Inc 's Income $ -2 million Quarterly DYAI's Income Statement
DYAI's Income by Division See DYAI's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 0.16 % 20.82 % -40.06 % -35.62 % -29.17 %
Total Assets in million 10 10 8 14 21
Y / Y Net Income Change - - - - -
Net Income in million -7 -6 -7 -10 -26
Annual Return On Assets -74.05 % -58.5 % -82.68 % -70.99 % -122.73 %

DYAI's 5 Years Annual ROA >> Back to DYAI Management Effectiveness >> Compare DYAI ROA to its Competitors



More Return On Assets Ratios
DYAI's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DYAI's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DYAI's Competitors
Subscribers only: Roa for Dyadic International Inc 's Suppliers
Subscribers only: Return On Assets for DYAI's Customers

You may also want to know
DYAI's Roi DYAI's Inventory Turnover Ratio DYAI's Growth Rates DYAI's Dividend Comparisons
DYAI's Profitability Ratios DYAI's Asset Turnover Ratio DYAI's Dividend Growth
DYAI's Roe DYAI's Valuation Ratios DYAI's Financial Strength Ratios DYAI's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-04T07:58:14+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.